Monro Q1 FY2027: Sales Down 4.6%, Adjusted Loss of $0.09/Share, No Guidance
MNRO sits 37% above its 52-week low of $12.255.
Summary
Monro reported Q1 FY2027 sales of $287.1M, down 4.6% year-over-year, with a net loss of $2.1M. Comparable store sales declined 1.7%. The company withheld fiscal 2027 guidance, citing a challenging consumer environment.
Key Events · Earnings and Guidance · MNRO
-
Sales Decline Continues
Q1 FY2027 sales fell 4.6% to $287.1M, driven by a 1.7% comparable store sales decrease and the impact of prior store closures. Tire and brake comparable sales each declined 1%, while maintenance services dropped 5%.
-
Adjusted Profitability Deteriorates
Adjusted operating income plunged to $2.2M (0.8% of sales) from $14.0M (4.7% of sales) a year ago, as higher marketing costs and occupancy expenses offset lower store closing costs. Adjusted diluted loss per share was $0.09 versus adjusted diluted EPS of $0.22.
-
Guidance Withheld
Monro did not provide fiscal 2027 financial guidance, stating it will offer perspective during the earnings call. This follows a strategic alternatives review announced in May 2026, heightening uncertainty around the company's standalone outlook.
-
Liquidity Remains Adequate
As of June 27, 2026, Monro had $9.5M in cash and $261.5M available under its credit facility, providing runway to navigate the current downturn.
Analysis · MNRO · Trade & Services
Monro's first quarter results show continued top-line pressure with a 4.6% sales decline and a 1.7% drop in comparable store sales, though the net loss narrowed significantly from the prior year. Adjusted operating income fell sharply to $2.2M from $14.0M, reflecting underlying margin weakness. The company is not providing full-year guidance, adding uncertainty. This comes against the backdrop of a strategic review announced in May 2026, making operational performance critical to any potential sale process.
At the time of this filing, MNRO was trading at $16.82 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $537.4M. The 52-week trading range was $12.26 to $23.91. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.